XML 23 R8.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 64,990 $ 43,237
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization of real estate, in-place lease and other intangibles 131,951 143,250
Amortization of deferred compensation 4,111 5,919
Amortization of deferred financing costs 2,699 3,336
Straight-line rents (5,091) (10,686)
Equity loss (income) from unconsolidated joint ventures 863 (570)
Distributions of earnings from unconsolidated joint ventures 5,232 5,336
Deferred income tax expense (benefit) (3,800) (2,394)
Impairments (recoveries), net 8,858 (3,298)
Loss (gain) on sales of real estate, net (8,044) (20,815)
Loss (gain) on consolidation, net 0 41,017
Other non-cash items 560 (2,401)
Decrease (increase) in accounts receivable and other assets, net (11,114) (18,082)
Increase (decrease) in accounts payable, accrued liabilities and deferred revenue (32,633) 12,315
Net cash provided by (used in) operating activities 158,582 196,164
Cash flows from investing activities:    
Acquisitions of real estate (106,298) (22,121)
Development and redevelopment of real estate (136,654) (113,648)
Leasing costs, tenant improvements, and recurring capital expenditures (19,220) (19,246)
Proceeds from sales of real estate, net 122,678 30,392
Contributions to unconsolidated joint ventures (3,870) (3,688)
Distributions in excess of earnings from unconsolidated joint ventures 5,497 7,257
Proceeds from sales/principal repayments on debt investments and direct financing leases 481 132,429
Investments in loans receivable, direct financing leases and other (22,891) (647)
Net cash provided by (used in) investing activities (160,277) 10,728
Cash flows from financing activities:    
Borrowings under bank line of credit 320,000 240,000
Repayments under bank line of credit (125,000) (170,000)
Repayments and repurchase of debt, excluding bank line of credit (2,437) (1,172)
Issuance of common stock and exercise of options 1,578 2,774
Repurchase of common stock (2,919) (2,144)
Dividends paid on common stock (177,286) (174,149)
Issuance of noncontrolling interests 0 995
Distributions to and purchase of noncontrolling interests (5,415) (67,542)
Net cash provided by (used in) financing activities 8,521 (171,238)
Effect of foreign exchanges on cash, cash equivalents and restricted cash (20) 111
Net increase (decrease) in cash, cash equivalents and restricted cash 6,806 35,765
Cash, cash equivalents and restricted cash, beginning of period 139,846 82,203
Cash, cash equivalents and restricted cash, end of period $ 146,652 $ 117,968